Born in Cleveland to Irish immigrants, Kathleen went to California to complete her undergraduate degree at Stanford. After another decade of education and receiving her M.D. at UCLA, training in internal medicine and infectious disease, and adventures around the US and globe, she returned to San Francisco and ran her own practice for more than 15 years. Most recently, Dr. Jordan served as the chief medical officer at Saint Francis Memorial, a Dignity Health hospital, working to improve the health of a complex community, starting new programs in use disorders, mental health, and gender health.
A percentage of patients infected with COVID-19 are now reporting lingering symptoms, with the most common symptom being fatigue. They likely incurred infection in the earlier months of 2020 when testing availability was sporadic and reserved for the most severely ill patients in many instances, so may not have had access to testing to confirm the acute diagnosis of COVID-19.1 April 2021
If you save one hospitalization and ICU stay, those dollars pay for tens of thousands of vaccinations. In comparison to COVID’s social distancing measures, which are far more costly, vaccination is a much more affordable solution.1 April 2021
I think vaccines have been the highlight of our response with some big wins. Obviously, the 95% efficacy from Pfizer and Moderna were incredible. I also think that 85% efficacy this morning from Johnson & Johnson on preventing severe disease is also incredible. People want these vaccines, because they don't want to die and they don't want to end up in the ICU. And those numbers are actually very impressive.
I mean, right now, we have 7% of the US population vaccinated, which is great. We have our health care workforce vaccinated, which makes our health care facilities safe. But we're poised to really roll out hundreds of millions more doses in the coming months. And I'm excited about where we are with vaccines. I do think we're a little bit away from herd immunity however. Remember, none of these vaccines are yet approved for children under 16, and that's 20% of our population. So we have 20% of our population that isn't going to be vaccinated, at least in the immediate future.
So we do need to also still keep our eye on the ball on other measures. We still need to double down on masking, infection control efforts. We still need to work out testing. I'd like to see some big wins coming out of testing that are more affordable and accessible with quick turnarounds, point of care. Imagine getting testing going into dinner parties or schools or any kind of communal gathering. So I think we're still looking for some wins, but we've had some real wins.1 April 2021